当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Azizul Haque
Mill operator Fisher Disorder (MFS) remains as a particular variation of Guillain-Barré Condition (GBS) portrayed by a group of three of side effects including ophthalmoplegia, ataxia, and areflexia. First recognized by nervous system specialist Charles Mill operator Fisher in 1956, this uncommon neurological problem offers a novel understanding into the perplexing transaction between the resistant framework and the sensory system. This refreshed account audit digs into the clinical indications, basic pathophysiology, demonstrative techniques, and current administration approaches for Mill operator Fisher Disorder. Mill operator Fisher condition (MFS) is viewed as an interesting variation of Guillain- Barré disorder (GBS), a gathering of intense beginning safe intervened neuropathies described by the exemplary ternion of ataxia, areflexia and ophthalmoparesis. The current survey means to give a nitty gritty and refreshed profile of all parts of the disorder through an assortment of distributed deals with the subject, going from beginning depiction to ongoing improvements connected with Coronavirus.